Udaya M. Kabadi糖尿病(英文)Kabadi UM. How low do we fall to lower hemoglobin A1c? SGLT2 Inhibitors: Effective Drugs or Expensive Toxins! Journal of Diabetes Mellitus. 2013;3(4): 199-201.
SGLT2 inhibitors improve hyperglycemia with a decline in body weight and blood pressure, the outcomes touted to be of major importance in management of type 2 diabetes. However, the efficacy in lowering glycemia is very modest and imparts an undue cost burden on patients. Moreover, the ...
[9]IsajiM.Sodium-glucosecotransporterinhibitorsfordiabetes[J].CurrOpinInvestigDrugs,2007,8(4):285-292. [10]UetaK,IshiharaT,MatsumotoY,eta1.Long-termtreatmentwiththeNa+-glucosecotransporterinhibitorT-1095causessustainedimprovementinhyperglyeemiaandpreventsdiabeticneuropathyinGoto-KakizakiRats.LifeSei,2005,22...
精品论文 参考文献 降糖新药-SGLT2抑制剂 崔志梅(通讯作者) 杨宏杰(上海中医药大学附属中西医结合岳阳医院内分泌科 200437) 【摘要】 钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂通过增加肾脏葡萄糖的排出量而改善糖尿病患者的高血糖状态,同时可减轻体重,对胰岛素敏感性和胰岛素分泌功能具有一定的保护作用。因此,SGLT2抑制...
[12]Sinha B, Ghosal S. A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2022 Feb 21;13:830401. doi: 10.3389/fendo.2022.830401. PMID: 35265039; PMCID: PMC8900375. ...
SOTA-THROMBOSIS: Antithrombotic Activities of Sotagliflozin Vs. Empagliflozin The availability of Sodium-glucose cotransporter-2 inhibitors (SGLT2-i) has dramatically altered the management of heart failure (HF) patients, independently of their ejection fraction and glycemic status. A meta-analysis of ...
SGLT-2 inhibitors: wonder drugs? Not so fast Author links open overlay panelK Williams, M DiMarco, J Hebert, WA Gibson, D Smith, BA Coe, A Ataei, K Hoppens, S Sanne, S VignesShow more Add to Mendeley Share Cite https://doi.org/10.1016/S0002-9629(24)00199-XGet rights and ...
Individuals with chronic kidney disease (CKD) are at an increased risk of heart failure; conversely, kidney function decline is common in individuals with heart failure. Sodium–glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of kidney disease progression and hospitalization for heart fai...
【Abstract】Sodium glucose co-transporters 2(SGLT2) inhibitors that improving diabetes hyperglycemia through increased renal glucose output has a certain protective effect on insulin sensitivity and insulin secretion function,as well as reduce weight.Therefore,SGLT2 inhibitors has become the domestic and ...
SGLT2 inhibitors – what it says on the tin Canagliflozin, dapagliflozin, empagliflozin and ertugliflozin are four currently available agents of the SGLT2-inhibitor class. All four are indicated for T2DM, while dapagliflozin recently received FDA approval for HF, with or without T2DM [6]. As the...